Index of artpub/2022/pmc_35075803/

Reverté, Laia
Fetuin-A, inter-α-trypsin inhibitor, glutamic acid and ChoE (18:0) are key biomarkers in a panel distinguishing mild from critical coronavirus disease 2019 outcomes
2022
https://ddd.uab.cat/record/252242